MAFA
ABBV icon

MJT & Associates Financial Advisory’s AbbVie ABBV Stock Holding History

MJT & Associates Financial Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$26.4K Buy
101
+3
+3% +$769 0.02% 97
2026
Q2 		$24.7K Buy
98
+16
+20% +$3.44K 0.02% 114
2026
Q1 		$17.8K Hold
82
– – 0.01% 127
2025
Q4 		$18.7K Hold
82
– – 0.01% 131
2025
Q3 		$19K Buy
82
+37
+82% +$7.54K 0.02% 128
2025
Q2 		$8.35K Hold
45
– – 0.01% 229
2025
Q1 		$9.43K Buy
+45
New +$8.75K 0.01% 214

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

MJT & Associates Financial Advisory's ABBV Position: Q3 2026 in Review

MJT & Associates Financial Advisory increased its AbbVie (ABBV) stake by 3.1% in Q3 2026, buying an estimated $769 and bringing the position to 101 shares worth $26.4K. The position accounts for 0.02% of the portfolio, ranked #97.

MJT & Associates Financial Advisory first reported a position in ABBV in Q1 2025 and has held it in 7 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • MJT & Associates Financial Advisory held 101 shares of AbbVie worth $26.4K as of Q3 2026.
  • MJT & Associates Financial Advisory bought 3 AbbVie shares in Q3 2026, an estimated $769.
  • AbbVie made up 0.02% of MJT & Associates Financial Advisory's portfolio in Q3 2026, its #97 holding.
  • MJT & Associates Financial Advisory first reported a position in AbbVie in Q1 2025 and has held it in 7 quarters since.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on MJT & Associates Financial Advisory's 13F filing for Q3 2026, filed 7 Oct 2026.